Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.670
-0.170 (-9.24%)
At close: Aug 7, 2025, 4:00 PM
1.620
-0.050 (-2.99%)
Pre-market: Aug 8, 2025, 8:00 AM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $51.54 million as of August 8, 2025. Its market cap has decreased by -56.81% in one year.
Market Cap
51.54M
Enterprise Value
51.23M
1-Year Change
-56.81%
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $51.54M, a decrease of -75.13%. That is a compound annual growth rate of -60.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 51.54M | -57.95% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 581.27B |
| Johnson & Johnson | 412.33B |
| AbbVie | 351.90B |
| Abbott Laboratories | 229.71B |
| AstraZeneca | 228.71B |
| Novartis AG | 221.76B |
| UnitedHealth Group | 220.87B |
| Merck & Co. | 201.55B |